Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
The Journal of Investigative Dermatology|November 26, 2013
Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biologyZoltan Pos, Tara L Spivey, Hui Liu, et al.
Journal for Immunotherapy of Cancer|January 4, 2024
Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single caseViviana Vallacchi, Elisabetta Vergani, Mara Cossa, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 13, 2021
Preventive Anti-inflammatory Diet to Reduce Gastrointestinal Inflammation in Familial Adenomatous Polyposis Patients: A Prospective Pilot StudyAntonino Belfiore, Chiara Maura Ciniselli, Stefano Signoroni, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2010
HLA-A*0201-restricted CEA-derived peptide CAP1 is not a suitable target for T-cell-based immunotherapyEmilie Fauquembergue, Olivier Toutirais, David Tougeron, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 29, 2024
Modulation of faecal miRNAs highlights the preventive effects of a Mediterranean low-inflammatory dietary interventionOscar Illescas, Giulio Ferrero, Antonino Belfiore, et al.
Cancer Research|May 3, 2006
Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursorsTiziana Di Pucchio, Lorenzo Pilla, Imerio Capone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2016
TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Armed Exosomes Deliver Proapoptotic Signals to Tumor SiteLicia Rivoltini, Claudia Chiodoni, Paola Squarcina, et al.
The Journal of Investigative Dermatology|September 10, 2016
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib TreatmentMarcella Tazzari, Valentina Indio, Barbara Vergani, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2013
Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell responseChiara Camisaschi, Paola Filipazzi, Marcella Tazzari, et al.
The Oncologist|August 6, 2021
Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated MelanomaLorenza Di Guardo, Giovanni Randon, Francesca Corti, et al.
Pageof 15